Impact of the COVID-19 pandemic on delays and disruptions in cancer services
Shah R, Hanna NM, Loo CE, David M, Mafra A, Fink H, et al. (2025). The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis. Nat Cancer. 6(1):194–204. https://doi.org/10.1038/s43018-024-00880-4 PMID:39747650
Impact of COVID-19 mitigation strategies on disruptions in cancer services
Shah R, Loo CE, Hanna NM, Hughes S, Mafra A, Fink H, et al. (2024). Global review of COVID-19 mitigation strategies and their impact on cancer service disruptions. J Cancer Policy. 41:100486. https://doi.org/10.1016/j.jcpo.2024.100486 PMID:38830535
Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination
Steinberg J, Hughes S, Hui H, Allsop MJ, Egger S, David M, et al. (2024). Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: a systematic review and meta-analysis. Int J Cancer. 154(8):1394–412. https://doi.org/10.1002/ijc.34798 PMID:38083979
Are patients with cancer at higher risk of COVID-19-related death?
Freeman V, Hughes S, Carle C, Campbell D, Egger S, Hui H, et al. (2022). Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence. J Cancer Policy. 33:100340. https://doi.org/10.1016/j.jcpo.2022.100340 PMID:35680113
The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer
Carle C, Hughes S, Freeman V, Campbell D, Egger S, Caruana M, et al. (2022). The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: a systematic review of the early evidence. J Cancer Policy. 33:100338. https://doi.org/10.1016/j.jcpo.2022.100338 PMID:35671919
Cancer incidence and mortality in Australia from 2020 to 2044
Luo Q, O’Connell DL, Yu XQ, Kahn C, Caruana M, Pesola F, et al. (2022). Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study. Lancet Public Health. 7(6):e537–48. https://doi.org/10.1016/S2468-2667(22)00090-1 PMID:35660215
COVID-19 and Cancer Global Modelling Consortium
Soerjomataram I, Bray F, Lansdorp-Vogelaar I, Ginsburg O, Rahal R, Sullivan R, et al.; COVID-19 and Cancer Global Modelling Consortium (2022). COVID-19 and Cancer Global Modelling Consortium (CCGMC): a global reference to inform national recovery strategies. J Cancer Policy. 32:100328. https://doi.org/10.1016/j.jcpo.2022.100328 PMID:35560265
Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic
Sarich P, Cabasag CJ, Liebermann E, Vaneckova P, Carle C, Hughes S, et al. (2022). Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: a systematic review and meta-analysis. EClinicalMedicine. 47:101375. https://doi.org/10.1016/j.eclinm.2022.101375 PMID:35434579